层A的遗传和药理学调制法纳基化决定了它的功能和营业额
Mattheus Xing Rong Foo1, Peh Fern Ong1, Zi Xuan Yap1
1A*STAR Skin Research Labs, Cell Ageing Laboratory, Skin Research Institute of Singapore, Singapore, Singapore.
Aging cell
|March 20, 2024
概括
恒久的发酵素化,而不是它的切断,导致Hutchinson-Gilford Progeria综合征 (HGPS) 细胞缺陷. 早期使用法内赛转移酶抑制剂 (FTIs) 治疗可以预防这些HGPS表型.
科学领域:
- 分子生物学分子生物学
- 细胞衰老 细胞衰老
- 遗传学 遗传学 是一个
背景情况:
- 哈森-吉尔福德进发症综合征 (HGPS) 是一种过早衰老疾病,由进发素 (progerin) 引起,这是一个突变的层状A蛋白.
- 孕的永久法尼基化和50氨基酸切断 (Δ50AA) 是关键特征,但它们在细胞缺陷中的个人作用仍然不清楚.
- 洛纳法尼布 (Lonafarnib) 是一种法尼西转移酶抑制剂 (FTI),其改善HGPS表型的机制尚未完全理解.
研究的目的:
- 为了阐明是否永久的Farnesylation或50AA的孕是负责HGPS细胞缺陷.
- 研究FTI治疗改善HGPS表型的作用机制.
- 确定FTI干预HGPS的最佳时间.
主要方法:
- 利用多西环素诱导系统来表达各种层A突变物.
- 对表达孕激素突变的细胞进行FTI治疗.
- 评估了细胞表型,孕积累和清除率.
主要成果:
- 永久的法尼基化,而不是 Δ50AA,仅仅驱动着孕诱导的细胞缺陷,包括衰老.
- 通过抑制孕激素的法尼基化,FTI治疗可以预防HGPS表型.
- 早期FTI治疗是有效的,而晚期治疗没有显著的益处,表明干预的关键时间窗口.
- FTIs不会增强Farnesylation后的孕清除.
结论:
- 永久性progerin farnesylation是HGPS细胞病理的主要驱动因素.
- FTI治疗有效地改善了HGPS表型,通过向素化.
- 在HGPS治疗疗效方面,FTI的时间非常重要.
- 这些发现对其他涉及永久法化蛋白质的疾病有影响.
相关概念视频
Disassembly of Intermediate Filaments
2.1K
Intermediate filaments (IFs) do not undergo spontaneous disassembly. Enzymes, kinases, and phosphatases add and remove phosphates from specific sites to regulate their disassembly. The IF concentration in the cytoplasm also regulates the disassembly. If the concentration crosses a threshold, it activates the protein kinases in the vicinity, allowing the phosphorylation of IFs.
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
2.1K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Actin Filament Depolymerization
3.1K
Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
In F-actin, the ADF/cofilin proteins...
3.1K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Regulation of Expression at Multiple Steps
904
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
904


